Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy? Source: Eur Respir J 2016; 47: 688-690 Year: 2016
Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study Source: Eur Respir J 2006; 28: Suppl. 50, 386s Year: 2006
Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry Source: Eur Respir J, 55 (5) 1901747; 10.1183/13993003.01747-2019 Year: 2020
Pulmonary embolism (PE): potencial risk factors and discrepancies between clinical and postmortem diagnosis in a referral hospital of lung diseases Source: Annual Congress 2007 - Venous thromboembolism Year: 2007
Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer? Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017
Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset Source: ERJ Open Res, 7 (4) 00431-2021; 10.1183/23120541.00431-2021 Year: 2021
Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011
A model for estimating the health economic impact of earlier diagnosis of chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 7 (3) 00719-2020; 10.1183/23120541.00719-2020 Year: 2021
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension Source: Eur Respir J, 50 (2) 1700889; 10.1183/13993003.00889-2017 Year: 2017
Improving patient outcomes in pulmonary hypertension Source: Eur Respir Rev 2015; 24: 550-551 Year: 2015
Survival and prognostic factors in patients with incident systemic sclerosis-associated pulmonary arterial hypertension from the French registry Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry Source: ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020 Year: 2021
New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension Source: Eur Respir Rev 2013; 22: 495-502 Year: 2013
Early improvements predict outcomes in pulmonary arterial hypertension Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension Year: 2018
Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis Source: Eur Respir J , 49 (2) 1602520; DOI: 10.1183/13993003.02520-2016 Year: 2017
Improving identification and early referral of pulmonary hypertension patients Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016
Predictors of poor outcome in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012
Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021 Year: 2021
Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004